EUVIMEDDescoperă EUVIMED
Open access

Assessing COVID-19 Mortality in Serbia’s Capital: Model-Based Analysis of Excess Deaths

Dane Cvijanovic iD, Nikola Grubor iD, Nina Rajovic iD, Mira Vucevic iD, Svetlana Miltenovic iD, Marija Laban iD, Tatjana Mostic iD, Radica Tasic iD, Bojana Matejic iD, Natasa Milic iD

JMIR Public Health and Surveillance · 2025

DOI: 10.2196/56877 ↗

At a glance

Journal article in JMIR Public Health and Surveillance, 2025. Written by Dane Cvijanovic and 9 co-authors. Institution: Department of Cardiovascular Diseases, University Clinical Center Zvezdara, Belgrade, Serbia. Major MEDLINE topics: COVID-19. 46 references. The full text is freely available in PubMed Central.

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Background

Concerns have been raised about discrepancies in COVID-19 mortality data, particularly between preliminary and final datasets of vital statistics in Serbia. In the original preliminary dataset, released daily during the ongoing pandemic, there was an underestimation of deaths in contrast to those reported in the subsequently released yearly dataset of vital statistics.

Objective

This study aimed to assess the accuracy of the final mortality dataset and justify its use in further analyses. In addition, we quantified the relative impact of COVID-19 on the death rate in the Serbian capital’s population. In the process, we aimed to explore whether any evidence of cause-of-death misattribution existed in the final published datasets.

Methods

Data were sourced from the electronic databases of the Statistical Office of the Republic of Serbia. The dataset included yearly recorded deaths and the causes of death of all citizens currently living in the territory of Belgrade, the capital of the Republic of Serbia, from 2015 to 2021. Standardization and modeling techniques were utilized to quantify the direct impact of COVID-19 and to estimate excess deaths. To account for year-to-year trends, we used a mixed-effects hierarchical Poisson generalized linear regression model to predict mortality for 2020 and 2021. The model was fitted to the mortality data observed from 2015 to 2019 and used to generate mortality predictions for 2020 and 2021. Actual death rates were then compared to the obtained predictions and used to generate excess mortality estimates.

Results

The total number of excess deaths, calculated from model estimates, was 3175 deaths (99% CI 1715-4094) for 2020 and 8321 deaths (99% CI 6975-9197) for 2021. The ratio of estimated excess deaths to reported COVID-19 deaths was 1.07. The estimated increase in mortality during 2020 and 2021 was 12.93% (99% CI 15.74%-17.33%) and 39.32% (99% CI 35.91%-39.32%) from the expected values, respectively. Those aged 0‐19 years experienced an average decrease in mortality of 22.43% and 23.71% during 2020 and 2021, respectively. For those aged up to 39 years, there was a slight increase in mortality (4.72%) during 2020. However, in 2021, even those aged 20‐39 years had an estimated increase in mortality of 32.95%. For people aged 60‐79 years, there was an estimated increase in mortality of 16.95% and 38.50% in 2020 and 2021, respectively. For those aged >80 years, the increase was estimated at 11.50% and 34.14% in 2020 and 2021, respectively. The model-predicted deaths matched the non-COVID-19 deaths recorded in the territory of Belgrade. This concordance between the predicted and recorded non-COVID-19 deaths provides evidence that the cause-of-death misattribution did not occur in the territory of Belgrade.

Conclusions

The finalized mortality dataset for Belgrade can be safely used in COVID-19 impact analysis. Belgrade experienced a significant increase in mortality during 2020 and 2021, with most of the excess mortality attributable to SARS-CoV-2. Concerns about increased mortality from causes other than COVID-19 in Belgrade seem misplaced as their impact appears negligible.

Subjects

MeSH terms (MEDLINE)

COVID-19HumansSerbiaMaleFemaleMiddle AgedAdultAgedAdolescentCause of DeathChildModels, StatisticalYoung AdultChild, PreschoolAged, 80 and overInfantMortality

Author keywords

COVID-19COVID-19 impactSARS-Cov-2Serbiacentralized health carecoronavirusdeath ratedeath tolldense populationexcess mortalityinfectious diseasepandemicpublic healthpulmonaryrespiratory

Authors and institutions

  • Department of Cardiovascular Diseases, University Clinical Center Zvezdara, Belgrade, Serbia.
  • Institute of Medical Statistics and Informatics, Faculty of Medicine, University of Belgrade, Dr Subotica 15, Belgrade, Serbia, 381 63367700.
  • The City Institute for Public Health, Belgrade, Serbia.
  • Clinic of Pulmonology, University Clinical Center of Serbia, Belgrade, Serbia.
  • Department of Anesthesiology, University Clinical Center of Serbia, Belgrade, Serbia.
  • The College of Health Sciences, Academy of Applied Studies Belgrade, Belgrade, Serbia.

ORCID profiles: Dane Cvijanovic, Nikola Grubor, Nina Rajovic, Mira Vucevic, Svetlana Miltenovic, Marija Laban, Tatjana Mostic, Radica Tasic, Bojana Matejic, Natasa Milic

Cite

APA

Cvijanovic, D., Grubor, N., Rajovic, N., Vucevic, M., Miltenovic, S., Laban, M., Mostic, T., Tasic, R., Matejic, B., & Milic, N. (2025). Assessing COVID-19 Mortality in Serbia’s Capital: Model-Based Analysis of Excess Deaths. JMIR Public Health and Surveillance. https://doi.org/10.2196/56877

Vancouver

Cvijanovic D, Grubor N, Rajovic N, Vucevic M, Miltenovic S, Laban M, et al. Assessing COVID-19 Mortality in Serbia’s Capital: Model-Based Analysis of Excess Deaths. JMIR Public Health and Surveillance. 2025. doi:10.2196/56877

BibTeX
@article{Cvijanovic2025,
  author = {Cvijanovic, Dane and Grubor, Nikola and Rajovic, Nina and Vucevic, Mira and Miltenovic, Svetlana and Laban, Marija and Mostic, Tatjana and Tasic, Radica and Matejic, Bojana and Milic, Natasa},
  title = {Assessing COVID-19 Mortality in Serbia’s Capital: Model-Based Analysis of Excess Deaths},
  journal = {JMIR Public Health and Surveillance},
  year = {2025},
  doi = {10.2196/56877}
}
Start for free →